Cardlytics, Inc. (NASDAQ:CDLX) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Cardlytics, Inc. (NASDAQ:CDLX) have received a consensus recommendation of “Hold” from the seven ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $6.92.

A number of research analysts have commented on CDLX shares. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th.

Insider Activity

In other Cardlytics news, CFO Alexis Desieno sold 8,854 shares of Cardlytics stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $3.67, for a total transaction of $32,494.18. Following the transaction, the chief financial officer now directly owns 121,976 shares in the company, valued at approximately $447,651.92. The trade was a 6.77 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Amit Gupta sold 46,857 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total value of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares in the company, valued at approximately $1,423,365.80. This represents a 10.07 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 111,454 shares of company stock valued at $391,864 in the last ninety days. 4.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CDLX. Tallon Kerry Patrick bought a new stake in Cardlytics in the 4th quarter valued at $37,000. Atom Investors LP bought a new stake in shares of Cardlytics in the third quarter valued at about $33,000. ProShare Advisors LLC bought a new stake in shares of Cardlytics in the fourth quarter valued at about $43,000. SG Americas Securities LLC bought a new position in shares of Cardlytics during the third quarter worth about $45,000. Finally, Intech Investment Management LLC bought a new position in shares of Cardlytics during the third quarter worth about $47,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Price Performance

Shares of CDLX stock opened at $2.69 on Monday. Cardlytics has a 1 year low of $2.67 and a 1 year high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm’s 50 day moving average is $3.42 and its 200-day moving average is $3.64. The firm has a market capitalization of $136.71 million, a price-to-earnings ratio of -0.44 and a beta of 1.54.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.